Suppr超能文献

癌细胞分泌的巨噬细胞集落刺激因子可诱导肿瘤髓样细胞中脂肪酸合酶和PPARβ/δ激活,从而导致肿瘤进展。

M-CSF from Cancer Cells Induces Fatty Acid Synthase and PPARβ/δ Activation in Tumor Myeloid Cells, Leading to Tumor Progression.

作者信息

Park Jonghanne, Lee Sang Eun, Hur Jin, Hong Eun Byeol, Choi Jae-Il, Yang Ji-Min, Kim Ju-Young, Kim Young-Chan, Cho Hyun-Jai, Peters Jeffrey M, Ryoo Seung-Bum, Kim Young Tae, Kim Hyo-Soo

机构信息

National Research Laboratory for Cardiovascular Stem Cell Niche, Seoul National University Hospital, Seoul 110-744, Korea; Innovative Research Institute for Cell Therapy, Seoul National University Hospital, Seoul 110-744, Korea; Cardiovascular Center and Department of Internal Medicine, Seoul National University Hospital, Seoul 110-744, Korea.

National Research Laboratory for Cardiovascular Stem Cell Niche, Seoul National University Hospital, Seoul 110-744, Korea; Innovative Research Institute for Cell Therapy, Seoul National University Hospital, Seoul 110-744, Korea.

出版信息

Cell Rep. 2015 Mar 10;10(9):1614-1625. doi: 10.1016/j.celrep.2015.02.024. Epub 2015 Mar 5.

Abstract

We investigate crosstalk between cancer cells and stromal myeloid cells. We find that Lewis lung carcinoma cells significantly induce PPARβ/δ activity in myeloid cells in vitro and in vivo. Myeloid cell-specific knockout of PPARβ/δ results in impaired growth of implanted tumors, and this is restored by adoptive transfer of wild-type myeloid cells. We find that IL-10 is a downstream effector of PPARβ/δ and facilitates tumor cell invasion and angiogenesis. This observation is supported by the finding that the CD11bIL-10 pro-tumoral myeloid cell is scarcely detected in tumors from myeloid-cell-specific PPARβ/δ knockout mice, where vessel densities are also decreased. Fatty acid synthase (FASN) is shown to be an upstream regulator of PPARβ/δ in myeloid cells and is induced by M-CSF secreted from tumor cells. Our study gives insight into how cancer cells influence myeloid stromal cells to get a pro-tumoral phenotype.

摘要

我们研究了癌细胞与基质髓样细胞之间的串扰。我们发现,Lewis肺癌细胞在体外和体内均可显著诱导髓样细胞中的PPARβ/δ活性。髓样细胞特异性敲除PPARβ/δ会导致植入肿瘤的生长受损,而野生型髓样细胞的过继转移可恢复这种情况。我们发现IL-10是PPARβ/δ的下游效应因子,并促进肿瘤细胞侵袭和血管生成。这一观察结果得到以下发现的支持:在髓样细胞特异性PPARβ/δ敲除小鼠的肿瘤中几乎检测不到CD11bIL-10促肿瘤髓样细胞,而这些小鼠的血管密度也降低了。脂肪酸合酶(FASN)被证明是髓样细胞中PPARβ/δ的上游调节因子,并由肿瘤细胞分泌的M-CSF诱导。我们的研究深入了解了癌细胞如何影响髓样基质细胞以获得促肿瘤表型。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验